CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Canagliflozin and metformin hydrochloride

Last Updated: October 10, 2018
Result type: Reports
Project Number: SR0480-000
Product Line: Common Drug Review

Generic Name: Canagliflozin and metformin hydrochloride

Brand Name: Invokamet

Manufacturer: Janssen Inc.

Indications: Diabetes mellitus, type 2

Submission Type: New

Project Status: Complete

Date Recommendation Issued: August 25, 2016

Recommendation Type: Reimburse with clinical criteria and/or conditions